FDA & Health Canada Emergency Use Authorized
Easy To Use Portable Point Of Care Rapid Test instrument
The Most Widely Available Rapid Point Of Care Test Across The USA & Canada
ID NOW is one of the most widely-available molecular point-of-care testing technologies in use in the U.S. Since its introduction in 2014, it has been used in physicians’ offices and urgent care centers to rapidly detect influenzas A & B, strep A, and respiratory syncytial virus (RSV). When faced with the threat of novel coronavirus, our scientists mobilized to quickly bring a new COVID-19 detection test to the fight against this deadly virus.
ID NOW is an FDA approved CLIA-waived instrument, which means that the technology can be used in settings outside the traditional hospital setting.
To conduct a test, a swab of the nose is taken. Then the swab is placed into an acidic liquid solution heated to 132.8⁰ F that cracks open the envelope of the SARS-CoV-2 virus, exposing its viral RNA.
Then the small device, about the size of a toaster and weighing only 6.6 pounds, amplifies the RNA hundreds of millions of times to make the virus detectable — returning test results in 13 minutes or less.
Contact Vennwest WeAir Sales For Your Client ID
Rapid Test Features
Fast Working: Positive results in 5 minutes, negative results in 13 minutes
Established Technology:Leading molecular point-of-care platform for Influenza A & B, Strep A and RSV testing in the US
XXXXHigh Sensitivity: Sensitivity Igg = 100% / Sensitivity Igm = 89.3%
Pricing Varies w/ Quantity and Current Market Conditions
Contact Us For Quotes of 500,000 Quantity & Over
ORDER & DELIVERY
Online Portal For Ordering
Products are delivered within 4 weeks